Altrova Health (FRA:WF8) LT-Debt-to-Total-Asset: 0.00 (As of Mar. 2026)


What is Altrova Health LT-Debt-to-Total-Asset?

Altrova Health FRA:WF8 LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Altrova Health's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.00.

Altrova Health's long-term debt to total assets ratio stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00).

Altrova Health  (FRA:WF8) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Altrova Health LT-Debt-to-Total-Asset Related Terms

Altrova Health LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Altrova Health's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Altrova Health LT-Debt-to-Total-Asset Chart

Altrova Health Annual Data
Trend Sep23 Sep24 Sep25
LT-Debt-to-Total-Asset
0.00 0.00 0.00

Altrova Health Quarterly Data
Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Altrova Health LT-Debt-to-Total-Asset Calculation

Altrova Health's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Sep. 2025 is calculated as

LT Debt to Total Assets (A: Sep. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Sep. 2025 )/Total Assets (A: Sep. 2025 )
=0/2
=0.00

Altrova Health's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=0/2.402
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Altrova Health (FRA:WF8) has a LT-Debt-to-Total-Asset of 0.00 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Altrova Health and its competitors.
Is Altrova Health's LT-Debt-to-Total-Asset too high?
Altrova Health's current LT-Debt-to-Total-Asset is 0.00.
How does Altrova Health's LT-Debt-to-Total-Asset compare to BLK and BX?
Altrova Health's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for an Asset Management company?
A good LT-Debt-to-Total-Asset depends on the Asset Management industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Altrova Health and its competitors. Altrova Health's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Altrova Health stock overvalued right now?
Altrova Health (FRA:WF8) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Altrova Health (FRA:WF8), the current LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Altrova Health Business Description

Other Exchanges SSPLF:USAROVA:Canada
Address 666 Burrard Street, 25th Floor, Vancouver, BC, CAN, V6C 2X8
Altrova Health Inc is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness. The Company is focused on supporting multiple products, brands, and growth pathways under one stronger corporate identity, expanding beyond any single product story to create a more durable business. The Company continues to evaluate opportunities to expand its product offerings across the public health and safety sector.